RecruitingNCT03624712

Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

Prospective, Tricentric Open Trial on the Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms


Sponsor

University Hospital Tuebingen

Enrollment

580 participants

Start Date

Jan 1, 2012

Study Type

OBSERVATIONAL

Conditions

Summary

Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting detailed medical data from women with uterine cancers (including cervical cancer, endometrial cancer, and uterine sarcomas) to build better predictive tools for treatment outcomes and to improve surgical and treatment approaches. **You may be eligible if...** - You have been diagnosed with a confirmed uterine cancer (cervical cancer, endometrial cancer, or sarcoma) - If your cancer can be surgically treated, you are undergoing laparoscopic, robot-assisted, or open surgery - You are 18 years or older - You are willing and able to participate in all study activities - You can communicate adequately in German **You may NOT be eligible if...** - You have had a serious acute illness in the past 4 weeks - You have an active or chronic psychiatric disorder - You are unable to understand the nature of the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTuterine neoplasms

Analysis of circulating (CTC) and disseminating tumor cells (DTC), determination of Human Papilloma Virus (HPV), Douglas cytology, DNA analysis in blood, proteome analysis, sentinel lymph node detection


Locations(1)

University Hospital Tuebingen, Department of Women's Health

Tübingen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03624712


Related Trials